Our journal, JPharmTech, which started to be published tri-annually (April, August, December) in 2020,
will be published biannually (June, December) as of 2021.
It is announced to all authors, readers and referees.
Journal of Pharmaceutical Technology “JPharmTech” is an online peer-reviewed journal following the guidelines provided by the International Committee of Medical Journal Editors (ICMJE) and Committee on Publication Ethics (COPE). All published articles in the JPharmTech will be assigned with a unique Digital Objective Identifier (DOI) provided by CrossRef and archived by the LOCKSS system, which guarantees long-term digital preservation of the paper.
JPharmTech is an open-access journal. It provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. The manuscripts submitted to the JPharmTech are double-blind peer-reviewed. Submitted manuscripts must not have been previously published elsewhere and not currently be under review by another journal.
Processing and publication are free of charge. JPharmTech publishes two issues per year (June and December) and accepts research articles and review articles on all aspects of pharmaceutical technology. Corresponding authors should submit their manuscripts through the online submission system of Dergipark.